Kolon TissueGene, Inc. (KOSDAQ:950160)
South Korea · Delayed Price · Currency is KRW 58,300
+4,500 (8.36%)
Nov 20, 2025, 3:30 PM KST
Kolon TissueGene Market Cap
Kolon TissueGene has a market cap or net worth of 4.48 trillion as of November 20, 2025. Its market cap has increased by 237.38% in one year.
Market Cap
4.48T
Enterprise Value
4.50T
Revenue
5.49B
Ranking
n/a
PE Ratio
n/a
Stock Price
58,300.00
Market Cap Chart
Since November 6, 2017, Kolon TissueGene's market cap has increased from 2.58T to 4.48T, an increase of 73.66%. That is a compound annual growth rate of 7.10%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 19, 2025 | 4.48T | 142.33% |
| Dec 30, 2024 | 1.85T | 181.73% |
| Dec 28, 2023 | 655.80B | 7.08% |
| Dec 29, 2022 | 612.43B | -76.74% |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Nov 6, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 86.90T |
| Celltrion | 40.49T |
| ALTEOGEN | 29.90T |
| SK Biopharmaceuticals | 9.93T |
| ABL Bio | 9.18T |
| Yuhan | 8.97T |
| Peptron | 7.28T |
| LigaChem Biosciences | 6.50T |